---
company: HeartCore Enterprises, Inc.
ticker: HTCR
form: 8-K
filed: 2026-05-15
accession: 0001493152-26-023376
source: https://www.sec.gov/Archives/edgar/data/1892322/000149315226023376/
---

# HeartCore Enterprises (HTCR) earnings release, May 15, 2026

HeartCore Enterprises, Inc. (HTCR) · Form 8-K, Item 2.02 · Filed 2026-05-15 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1892322/000149315226023376/)

Exhibit

99.1

HeartCore

Reports First Quarter 2026 Financial Results

NEW

YORK and TOKYO, May 15, 2026 (GLOBE NEWSWIRE) – HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the first quarter ended March 31, 2026.

Recent

Operational Highlights

Management

Commentary

HeartCore

CEO Sumitaka Kanno commented: “During the first quarter of 2026, HeartCore continued to advance its strategic focus on financial services and capital markets-related services, with Go IPO remaining the key contributor for coming quarters. While the Nasdaq listing environment has become selective and increasingly focused on compliance, we continue to see interest from Japanese and other Asia-based companies seeking access to the U.S. capital markets. In light of these current market conditions, we are focused on expanding the number of engagements and enhancing the overall quality of our pipeline by prioritizing clients that we believe demonstrate stronger listing readiness and long-term financing potential.

“Through our subsidiary Higgs Field Co., Ltd., we are also taking steps to support potential expansion into additional financial services and sectors, including digital securities and capital markets advisory services. During the first quarter, we added experienced financial industry personnel and further developed our organizational structure as we prepare to seek a Type I Financial Instruments business license in Japan. We are also working with external professionals and industry organizations to further strengthen our internal management and compliance framework.

“Looking ahead, we remain focused on broadening our Go IPO client base that aligns with Nasdaq’s tightened requirements and diversifying our revenue base as we further develop and advance our financial services business.”

First

Quarter 2026 Financial Results

Revenues were $1.2 million compared to $2.1 million in the same period last year. The decrease was primarily due to a decline in customized software development and services revenue as a result of intense competition in the U.S. software market.

Gross profit was $74,000 compared to $0.5 million in the same period last year. The decrease was primarily due to lower gross profit from Go

IPO consulting services resulting from increased outsourcing fees and additional resources invested to enhance customer experience, as well as lower gross profit from customized software development and services due to decreased revenues and higher subcontracting costs for outsourced software engineers amid rising salary levels in the software market.

Operating expenses decreased to $1.6 million compared to $1.7 million in the same period last year. The decrease was primarily due to a decrease in selling expenses.

Net loss was $2.0 million compared to a loss of $3.1 million in the same period last year. The improvement was primarily due to a reduction in the loss on the fair value of investments in marketable securities.

Adjusted

EBITDA was a loss of $1.6 million compared to a loss of $1.3 million in the same period last year.

As of March 31, 2026, the Company had cash and cash equivalents of $0.8 million.

About

HeartCore Enterprises, Inc.

HeartCore

Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese corporate clients. For more information, please visit https://heartcore-enterprises.com/.

Non-GAAP

Financial Measures

This document includes references to adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, adjusted

EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, interest income, and interest expenses.

This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).

Management believes that adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.

Forward-Looking

Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section

21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,”

“potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission.

Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and... (truncated)ect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCore

Investor Relations Contact:

Gateway

Group, Inc.

John

Yi and Steven Shinmachi

HTCR@gateway-grp.com

(949)

574-3860

HEARTCORE

ENTERPRISES, INC.

## Financial statements

### Income Statement (For the Three Months — Unaudited Consolidated Statements of Operations and Comprehensive Loss)

| | For the Three Months – Ended March 31, – 2026 | For the Three Months – Ended March 31, – 2025 |
|---|---:|---:|
| Revenues | 1,245,844 | 2,093,413 |
| Cost of revenues (including cost of revenues resulting from transactions with a related party of $114,535 and $25,195 for the three months ended March 31, 2026 and 2025, respectively) | 1,171,799 | 1,549,639 |
| Gross profit | 74,045 | 543,774 |
| Operating expenses: | Selling expenses | 42,812 | 152,922 |
| Operating expenses: | General and administrative expenses (including general and administrative expenses resulting from transactions with a related party of nil and $17,615 for the three months ended March 31, 2026 and 2025, respectively) | 1,571,734 | 1,581,205 |
| Operating expenses: | Total operating expenses | 1,614,546 | 1,734,127 |
| Operating expenses: | Loss from continuing operations | -1,540,501 | -1,190,353 |
| Other income (expenses): | Changes in fair value of investments in marketable securities | -295,997 | -1,781,664 |
| Other income (expenses): | Changes in fair value of investment in warrants | -7,065 | -51,621 |
| Other income (expenses): | Changes in fair value of derivative liability | -870 |  |
| Other income (expenses): | Interest income | 582 | 2,243 |
| Other income (expenses): | Interest expenses | -16,625 | -17,794 |
| Other income (expenses): | Other income | 14,095 | 9,313 |
| Other income (expenses): | Other expenses | -112,865 | -547 |
| Other income (expenses): | Total other expenses | -418,745 | -1,840,070 |
| Other income (expenses): | Loss from continuing operations before income tax expense | -1,959,246 | -3,030,423 |
| Other income (expenses): | Income tax expense | 17,469 | 39,608 |
| Other income (expenses): | Net loss from continuing operations | -1,976,715 | -3,070,031 |
| Other income (expenses): | Loss from discontinued operations, net of income tax |  | -67,350 |
| Other income (expenses): | Net loss | -1,976,715 | -3,137,381 |
| Other income (expenses): | Less: net loss attributable to non-controlling interests | -105,008 | -50,389 |
| Other income (expenses): | Net loss attributable to HeartCore Enterprises, Inc. | -1,871,707 | -3,086,992 |
| Other income (expenses): | Dividends accrued on Series A convertible preferred shares | -27,968 |  |
| Other income (expenses): | Net loss attributable to HeartCore Enterprises, Inc. common shareholders | -1,899,675 | -3,086,992 |
| Other comprehensive loss: | Foreign currency translation adjustment | -16,140 | -8,014 |
| Other comprehensive loss: | Total comprehensive loss | -1,992,855 | -3,145,395 |
| Other comprehensive loss: | Less: comprehensive loss attributable to non-controlling interests | -113,546 | -49,152 |
| Other comprehensive loss: | Comprehensive loss attributable to HeartCore Enterprises, Inc. | -1,879,309 | -3,096,243 |
| Net loss from continuing operations attributable to HeartCore Enterprises, Inc. per common share* | Basic | -1.49 | -2.74 |
| Net loss from continuing operations attributable to HeartCore Enterprises, Inc. per common share* | Diluted | -1.49 | -2.74 |
| Loss from discontinued operations per common share* | Basic | $- | -0.06 |
| Loss from discontinued operations per common share* | Diluted | $- | -0.06 |
| Net loss attributable to HeartCore Enterprises, Inc. per common share* | Basic | -1.49 | -2.8 |
| Net loss attributable to HeartCore Enterprises, Inc. per common share* | Diluted | -1.49 | -2.8 |
| Weighted average common shares outstanding* | Basic | 1,271,631 | 1,102,702 |
| Weighted average common shares outstanding* | Diluted | 1,271,631 | 1,102,702 |

### Balance Sheet (December 31, — CONSOLIDATED BALANCE SHEETS)

| | March 31, – 2026 | December 31, – 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 774,033 | 1,985,962 |
| Current assets: | Accounts receivable | 572,547 | 707,865 |
| Current assets: | Investments in marketable securities | 3,394,190 | 3,690,187 |
| Current assets: | Prepaid expenses | 222,818 | 182,077 |
| Current assets: | Current portion of long-term note receivable | 100,000 | 100,000 |
| Current assets: | Deferred offering costs | 250,000 | 250,000 |
| Current assets: | Other current assets | 175,335 | 208,503 |
| Current assets: | Proceeds receivable from sale of discontinued operations | 1,382,897 | 1,291,298 |
| Current assets: | Total current assets | 6,871,820 | 8,415,892 |
| Non-current assets: | Property and equipment, net | 279,185 | 291,589 |
| Non-current assets: | Operating lease right-of-use assets | 506,456 | 29,449 |
| Non-current assets: | Long-term investment in warrants | 273,859 | 280,924 |
| Non-current assets: | Deferred tax assets | 22,633 | 23,121 |
| Non-current assets: | Security deposits | 278,154 | 282,958 |
| Non-current assets: | Other non-current assets | 241 | 549 |
| Non-current assets: | Long-term proceeds receivable from sale of discontinued operations | 3,539,421 | 3,736,995 |
| Non-current assets: | Total non-current assets | 4,899,949 | 4,645,585 |
| Non-current assets: | Total assets | 11,771,769 | 13,061,477 |
| Current liabilities: | Accounts payable and accrued expenses | 1,230,686 | 1,146,501 |
| Current liabilities: | Accounts payable and accrued expenses - related party | 96,333 | 124,618 |
| Current liabilities: | Accrued payroll and other employee costs | 663,683 | 509,547 |
| Current liabilities: | Due to related party | 401 | 285 |
| Current liabilities: | Short-term debt - related party | 69,000 | 75,000 |
| Current liabilities: | Current portion of long-term debts | 51,697 | 50,598 |
| Current liabilities: | Insurance premium financing | 97,773 | 13,430 |
| Current liabilities: | Factoring liability | 124,508 | 135,982 |
| Current liabilities: | Operating lease liabilities, current | 308,119 | 32,793 |
| Current liabilities: | Income tax payables | 1,847,411 | 1,857,386 |
| Current liabilities: | Deferred revenue | 650,469 | 676,216 |
| Current liabilities: | Derivative liability | 122,589 | 121,719 |
| Current liabilities: | Other current liabilities | 598,602 | 586,175 |
| Current liabilities: | Total current liabilities | 5,861,271 | 5,330,250 |

### Balance Sheet (For the Three Months — Unaudited Consolidated Statements of Cash Flows)

| | For the Three Months – Ended March 31, – 2026 | For the Three Months – Ended March 31, – 2025 |
|---|---:|---:|
| Cash flows from operating activities of continuing operations: | Net loss | -1,976,715 | -3,137,381 |
| Cash flows from operating activities of continuing operations: | Loss from discontinued operations, net of income tax |  | -67,350 |
| Cash flows from operating activities of continuing operations: | Net loss from continuing operations | -1,976,715 | -3,070,031 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Depreciation expense | 7,720 | 20,289 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Loss on disposal of property and equipment |  | 116,981 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Non-cash lease expense | 70,229 | 31,662 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Gain on termination of lease |  | -9,059 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Deferred income taxes |  | 27,515 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Stock-based compensation | 2,031 | 32,280 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Changes in fair value of investments in marketable securities | 295,997 | 1,781,664 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Changes in fair value of investment in warrants | 7,065 | 51,621 |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Changes in fair value of derivative liability | 870 |  |
| Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations: | Gain on settlement of asset retirement obligations |  | -45,873 |
| Changes in assets and liabilities: | Accounts receivable | 135,238 | -180,823 |
| Changes in assets and liabilities: | Prepaid expenses | 66,924 | 50,591 |
| Changes in assets and liabilities: | Other assets | 107,886 | -26,711 |
| Changes in assets and liabilities: | Accounts payable and accrued expenses | 85,404 | -97,118 |
| Changes in assets and liabilities: | Accounts payable and accrued expenses - related party | -28,338 | -24,224 |
| Changes in assets and liabilities: | Accrued payroll and other employee costs | 154,736 | -23,483 |
| Changes in assets and liabilities: | Due to related party | 125 | -884 |
| Changes in assets and liabilities: | Operating lease liabilities | -60,127 | -24,435 |
| Changes in assets and liabilities: | Income tax payables | -9,785 | -80,196 |
| Changes in assets and liabilities: | Deferred revenue | -25,747 | -233,911 |
| Changes in assets and liabilities: | Other liabilities | 12,897 | 12,686 |
| Changes in assets and liabilities: | Net cash flows used in operating activities of continuing operations | -1,153,590 | -1,691,459 |
| Cash flows from investing activities of continuing operations: | Purchases of property and equipment | -954 |  |
| Cash flows from investing activities of continuing operations: | Proceeds from sale of marketable securities |  | 462,763 |
| Cash flows from investing activities of continuing operations: | Net cash flows provided by (used in) investing activities of continuing operations | -954 | 462,763 |
| Cash flows from financing activities of continuing operations: | Payments for finance lease |  | -4,071 |
| Cash flows from financing activities of continuing operations: | Repayment of long-term debts | -12,382 | -10,561 |
| Cash flows from financing activities of continuing operations: | Repayment of related party debt | -6,000 |  |
| Cash flows from financing activities of continuing operations: | Repayment of insurance premium financing | -23,657 | -28,559 |
| Cash flows from financing activities of continuing operations: | Net repayment of factoring arrangement | -11,474 | -45,341 |
